ScreenPoint - About the company
ScreenPoint is a series C company based in Nijmegen (Netherlands), founded in 2014 by Michael Brady and Nico Karssemeijer. It operates as a Developer of artificial intelligence software for analyzing breast imaging mammograms. ScreenPoint has raised $47M in funding from Insight Partners and Siemens. The company has 405 active competitors, including 100 funded and 32 that have exited. Its top competitors include companies like Oxipit, Optellum and Niramai.
Company Details
Developer of artificial intelligence software for analyzing breast imaging mammograms. This technology integrates with existing medical imaging hardware to assist radiologists in detecting cancer. The software provides automated analysis of breast density and compares current images against previous examinations to identify potential abnormalities. It functions across various imaging systems to support clinical workflows in diagnostic environments.
- Website
- screenpoint-medical.com
- Social
- Email ID
- *****@screenpointmed.com
- Phone Number
- +31 **********
Key Metrics
Founded Year
2014
Location
Nijmegen, Netherlands
Stage
Series C
Total Funding
$47M in 4 rounds
Latest Funding Round
Investors
Ranked
1st among 405 active competitors
Employee Count
89 as on Oct 31, 2026
Investment & Acquisitions
Similar Companies
Sign up to download ScreenPoint's company profile
ScreenPoint's funding and investors
ScreenPoint has raised a total funding of $47M over 4 rounds. Its first funding round was on May 31, 2018. Its latest funding round was a Series C round on Apr 20, 2026 for $*****. 2 investors participated in its latest round. ScreenPoint has 5 institutional investors.
Here is the list of recent funding rounds of ScreenPoint:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 20, 2026 | 2817292 | Series C | 6424304 | 1766327 | 6322937 | 5447397 |
Apr 20, 2026 | 1253031 | Grant (prize money) | 4549361 | 4505081 | 2776020 | 2827099 |
Jul 27, 2021 | 9713840 | Series C | 3912123 | 4619049 |
Access funding benchmarks and valuations. Sign up today!View details of ScreenPoint's funding rounds and investors
ScreenPoint's founders and board of directors
Founder? Claim ProfileThe founders of ScreenPoint are Michael Brady and Nico Karssemeijer. Pieter Kroese is the CEO of ScreenPoint.
Here are the details of ScreenPoint's key team members:
- Michael Brady: Co-Founder & Chairman of ScreenPoint and founder of 2 other companies, Transpara Breast Care and Perspectum. Contact Info: 1 email address
- Nico Karssemeijer: Co-Founder & CSO of ScreenPoint and founder of 1 other company.
- Pieter Kroese: CEO of ScreenPoint.
View details of ScreenPoint's Founder profiles and Board Members
ScreenPoint's employee count trend
ScreenPoint has 89 employees as of Oct 26. Here is ScreenPoint's employee count trend over the years:
Uncover ScreenPoint's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ScreenPoint's Competitors and alternates
Top competitors of ScreenPoint include Oxipit, Optellum and Niramai. Here is the list of Top 10 competitors of ScreenPoint, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ScreenPoint 2014, Nijmegen (Netherlands), Series C | Developer of artificial intelligence software for analyzing breast imaging mammograms | $47M | 65/100 | |
2nd | Developer of medical imaging software for automated radiology diagnostic support | $6.69M | 64/100 | ||
3rd | Optellum 2015, Oxford (United Kingdom), Series A | Provider of AI-based cancer diagnostics platform | $20.6M | 64/100 | |
4th | AI-powered thermal imaging platform for radiation-free breast cancer screening | $8.63M | 61/100 | ||
5th | PreludeDx 2009, Laguna Hills (United States), Series B | Provider of risk assessment test for early stage breast cancer | $51.7M | 59/100 | |
6th |  Vista 2012, Palo Alto (United States), Series B | AI-guided software for clinicians to automate MRI exams | $38.2M | 59/100 | |
7th | Skin Analytics 2012, London (United Kingdom), Series B | Provider of smartphone based skin cancer detection | $32.6M | 58/100 | |
8th | AI-based imaging software for the diagnosis of brain disease | $29.5M | 58/100 | ||
9th | Olea Medical 2008, La Ciotat (France), Acquired | Developer of medical diagnostic software solutions for image post-processing | $6.7M | 57/100 | |
10th | Lantheus 2008, Billerica (United States), Acquired | Developer of diagnostic imaging agents and targeted therapeutics | - | 56/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on ScreenPoint's competitors? Click here to see the top ones
ScreenPoint's Investments and acquisitions
ScreenPoint has acquired Biomediq. ScreenPoint has not made any investments as of now.Reports related to ScreenPoint
Here is the latest report on ScreenPoint's sector:
News related to ScreenPoint
Filter this listMedia has covered ScreenPoint for a total of 9 events in the last 1 year, 5 of them have been about company updates and 2 about partnerships.
•
ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer CarePR Newswire•Apr 17, 2026•ScreenPoint, Insight Partners, Siemens Healthineers
•
•
ScreenPoint Medical: Transpara AI impacts MASAI trial's final endpointPR Newswire•Jan 30, 2026•ScreenPoint
•
ScreenPoint Medical & Ferrum Health Partner to Offer Transpara Breast AI Through Ferrum's AI Governance SuiteBenzinga•Jan 13, 2026•Ferrum Health, ScreenPoint
•
Microsoft to invest $5B in Anthropic, as Claude maker commits $30B to Azure in new Nvidia allianceGeekWire•Nov 18, 2025•Microsoft, Anthropic, Nvidia, Microsoft Azure and 1 other
•
ScreenPoint Medical's Transpara Breast AI Selected for $16M PRISM Randomized Controlled Trial in USAPR Newswire•Sep 23, 2025•ScreenPoint
•
AI boosts breast cancer detection accuracy and eases radiologist workload in mammography.PR Newswire•Feb 17, 2025•ScreenPoint
•
AI boosts mammogram accuracy, helping detect breast cancer earlier and easing radiologist workload.PR Newswire•Feb 07, 2025•ScreenPoint
•
ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment CapabilitiesJan 08, 2025•ScreenPoint, Biomediq
•
Screenpoint Medical acquires Biomediq a/s to the possibilities ofPresseportal•Jan 08, 2025•ScreenPoint, Biomediq
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about ScreenPoint
Explore our recently published companies
- Inertia Engineering and Machine Works - Stockton based, 1995 founded, Acquired company
- Industrial Control - Zeeland based, 1996 founded, Acquired company
- HVAX - Mumbai based, 2010 founded, Public company
- Pleno - Berlin based, 2023 founded, Acquired company
- NanoDrug Delivery - Hannover based, 2022 founded, Unfunded company
- Illumagear - Seattle based, 2012 founded, Series A company
